Frugality and performance in the age of AI: Biogaran reinvents its IT strategy

Biogaran, a pioneering laboratory in generic medicine in France, turned to Onepoint to adapt its IT strategy to face new economic and technological challenges.

Artificial Intelligence and Cloud are key accelerators of its mission: making quality medicines accessible to all French people across the country.

Biogaran, a Key Player in a Tense Sector in France

A pioneer in generic medicine in France, created in 1996, Biogaran today covers a broad spectrum of pathologies, from everyday ailments to the most serious diseases. With over 1,000 drug references and services aimed at improving adherence, Biogaran plays a major role in the health of the French population. Biogaran’s gross revenue amounts to 1.39 billion from its reimbursable generic products. Over the last 12 months, Biogaran sold 347 million boxes of medications in France. This represents more than 1 in 8 reimbursable medicine boxes in France.

The generic drug market in France is facing significant pressure: price cuts, raw material shortages, and increased regulatory demands. In this context, Biogaran must combine performance, agility, and innovation to remain competitive and ensure the availability of its medicines.

Defining an Ambitious and Pragmatic IT Trajectory

Onepoint was tasked with supporting the definition of a three-year IT strategy, aligned with business challenges and the opportunities offered by AI.

Creating a Common Language Between IT and Business

Map Biogaran’s “business capabilities” to establish a dialogue between IT and business.
Identify differentiating, critical, and future capabilities to better guide technological choices.
Evaluate the existing application portfolio to identify areas for improvement and their business impact.

Aligning IT Strategy with the Business Vision

Decode the key principles of Biogaran’s strategy to ensure IT-business coherence.
Define “IT principles” as a compass to guide technological decisions.
Communicate these principles widely to reinforce the IT department’s mission.

Building an Ambitious and Realistic IT Roadmap

Define an ideal technological target aligned with strategic challenges and identified opportunities.
Analyze the gaps with the current project portfolio and identify transformation levers.
Structure a pragmatic implementation plan, prioritizing initiatives based on their value and feasibility.
A Winning Technological Strategy: Relying on Robust Platforms

For several years, Biogaran has focused on application convergence around a few reference SaaS solutions, combined with a PaaS Data Platform and a multimodal intermediary layer. Onepoint confirmed the relevance of this approach and recommended accelerating its deployment:

  • Efficiency Gains: Optimizing processes and adopting industry best practices.
  • Facilitated Interconnection: Strengthened collaboration with partners and institutions.
  • Increased Scalability: Better adaptation to business changes and market fluctuations.
  • Simplified IT Management: Less maintenance, more added value for the IT department.

AI as a lever for transformation: controlled adoption and precise targeting

Biogaran committed early to leveraging data and opportunities related to generative AI.
Onepoint and Biogaran’s IT department developed an AI acceleration plan combining quick execution and cost control, structured around four principles:

Onepoint, strategic partner in digital transformation, data, and AI at Biogaran

With its expertise in IT Strategy and Life Sciences, Onepoint continues to support Biogaran in defining and implementing a digital, data, and AI roadmap aligned with the economic and regulatory challenges of the pharmaceutical sector.

Discover the testimony of Frédéric Riou, CIO of Biogaran.

Does this client case resonate with your organization? Discover our expertise.

 

 

 

Sources

  • Internal Data – January 2025
  • GERS Sell-In Data for Metropolitan France as of: December 24
  • GERS Sell-In Data for Metropolitan France as of: December 24
  • GERS Sell-In Data for Metropolitan France as of: December 24